The relationship between plasma concentration of paroxetine and CYP2D6 genotype in Japanese psychiatric patients

被引：0
|
作者：
Ueda, M [1 ]
Hirokane, G [1 ]
Morita, S [1 ]
Yokono, A [1 ]
Okawa, M [1 ]
Shimoda, K [1 ]
机构：
[1] Shiga Univ Med Sci, Otsu, Shiga 52021, Japan
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S223 / S223
页数：1
相关论文
共 50 条
  • [21] CYP2D6 genotype in psychiatric patients:: Impact on haloperidol metabolism.
    Schmider, J
    Sachse, C
    Walter, S
    Filler, D
    Kaiser, R
    Roots, I
    Brockmöller, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 185 - 185
  • [22] Correction to: Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects
    Eui Hyun Jung
    Choong-Min Lee
    Ji-Yeong Byeon
    Hyo-Bin Shin
    Kyung-Yul Oh
    Chang-Keun Cho
    Chang Woo Lim
    Choon-Gon Jang
    Seok-Yong Lee
    Yun Jeong Lee
    Archives of Pharmacal Research, 2021, 44 : 323 - 323
  • [23] Effect of CYP2D6 genotype on duloxetine serum concentration
    Hole, Kristine
    Gangso, Sofie
    Jensstuen, Asa Tonette
    Ormoy, Hanne Holte
    Paulsen, Maren
    Molden, Espen
    Haslemo, Tore
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 134 (01) : 186 - 192
  • [24] Is CYP2D6 phenotype predictable from CYP2D6 genotype?
    Kiss, Adam Ferenc
    Toth, Katalin
    Juhasz, Cintia
    Temesvari, Manna
    Paulik, Jozsef
    Hirka, Gabor
    Monostory, Katalin
    MICROCHEMICAL JOURNAL, 2018, 136 : 209 - 214
  • [25] Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patients
    Lohmann, PL
    Rao, ML
    Ludwig, M
    Griese, EU
    Zanger, UM
    Mörike, K
    Maier, W
    Bagli, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (04) : 289 - 295
  • [26] Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patients
    P. Lohmann
    M. Rao
    M. Ludwig
    E. Griese
    U. Zanger
    K. Mörike
    W. Maier
    M. Bagli
    European Journal of Clinical Pharmacology, 2001, 57 : 289 - 295
  • [27] Effects of number of CYP2D6 mutated alleles on steady-state plasma concentration of paroxetine
    Sawamura, K
    Suzuki, Y
    Kawashima, Y
    Sato, S
    Shimoda, K
    Someya, T
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (03) : 181 - 182
  • [28] Haloperidol and risperidone plasma concentration in Japanese psychiatric subjects with CYP2D6*10A,*2 and its gene duplication
    Ohnuma, T
    Matsubara, Y
    Shibata, N
    Arai, H
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S78 - S78
  • [29] CYP2D6 genotype and phenotype relationship in South Indians
    Naveen, A. T.
    Prasanna, T.
    Farzana, B. L.
    Rajan, S.
    Adithan, C.
    JOURNAL OF POSTGRADUATE MEDICINE, 2006, 52 (04) : 253 - 256
  • [30] Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia
    Doki, Kosuke
    Homma, Masato
    Kuga, Keisuke
    Kusano, Kazutomi
    Watanabe, Shigeyuki
    Yamaguchi, Iwao
    Kohda, Yukinao
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (11) : 919 - 926
12345